
GSK plc (GSK) - Financial and Strategic SWOT Analysis Review
Description
GSK plc (GSK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:
GSK plc (GSK) is a healthcare company that focuses on developing, manufacturing and commercializing general medicines, specialty medicines and vaccines. It offers drugs for the treatment of diseases such as HIV, respiratory, cancer, immuno-inflammation, anti-viral, central nervous system (CNS), metabolic, cardiovascular, and urogenital, anti-bacterial, dermatology and rare diseases. The company also offers over-the-counter (OTC) products for pain relief, oral health, nutrition, skin health and gastrointestinal diseases. GSK’s vaccine portfolio covers various diseases including hepatitis, diphtheria, tetanus, whooping cough, rotavirus and HPV infections, measles and bacterial meningitis, among others. The company sells its products through wholesalers, pharmacies, hospitals, physicians and other groups worldwide. GSK is headquartered in London, England, the UK.
GSK plc Key Recent Developments
May 15,2025: New Allegations About Timing of Pfizer COVID Vaccine Passed To House Panel
May 09,2025: GSK and Lifetime Launch Original Movie To Raise Awareness About the Impact of Meningitis
Apr 30,2025: GSK Announces Q1 Results
Apr 15,2025: Abu Dhabi Investment Office and GSK sign agreement to establish Multi-Omics Research Institute in Abu Dhabi during Abu Dhabi Global Health Week 2025
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note:Some sections may be missing if data is unavailable for the company
The profile contains critical company information including:
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
GSK plc (GSK) is a healthcare company that focuses on developing, manufacturing and commercializing general medicines, specialty medicines and vaccines. It offers drugs for the treatment of diseases such as HIV, respiratory, cancer, immuno-inflammation, anti-viral, central nervous system (CNS), metabolic, cardiovascular, and urogenital, anti-bacterial, dermatology and rare diseases. The company also offers over-the-counter (OTC) products for pain relief, oral health, nutrition, skin health and gastrointestinal diseases. GSK’s vaccine portfolio covers various diseases including hepatitis, diphtheria, tetanus, whooping cough, rotavirus and HPV infections, measles and bacterial meningitis, among others. The company sells its products through wholesalers, pharmacies, hospitals, physicians and other groups worldwide. GSK is headquartered in London, England, the UK.
GSK plc Key Recent Developments
May 15,2025: New Allegations About Timing of Pfizer COVID Vaccine Passed To House Panel
May 09,2025: GSK and Lifetime Launch Original Movie To Raise Awareness About the Impact of Meningitis
Apr 30,2025: GSK Announces Q1 Results
Apr 15,2025: Abu Dhabi Investment Office and GSK sign agreement to establish Multi-Omics Research Institute in Abu Dhabi during Abu Dhabi Global Health Week 2025
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note:Some sections may be missing if data is unavailable for the company
Table of Contents
- Section 1 - About the Company
- GSK plc - Key Facts
- GSK plc - Key Employees
- GSK plc - Key Employee Biographies
- GSK plc - Major Products and Services
- GSK plc - History
- GSK plc - Company Statement
- GSK plc - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
- Joint Venture
- Section 2 – Company Analysis
- Company Overview
- GSK plc - Business Description
- Business Segment: Commercial operations
- Overview
- Performance
- Business Segment: Total R&D
- Overview
- Geographical Segment: Rest of World
- Performance
- Geographical Segment: UK
- Performance
- Geographical Segment: US
- Performance
- R&D Overview
- GSK plc - Corporate Strategy
- GSK plc - SWOT Analysis
- SWOT Analysis - Overview
- GSK plc - Strengths
- GSK plc - Weaknesses
- GSK plc - Opportunities
- GSK plc - Threats
- GSK plc - Key Competitors
- Section 3 – Company Financial Ratios
- Financial Ratios - Capital Market Ratios
- Financial Ratios - Annual Ratios
- Performance Chart
- Financial Performance
- Financial Ratios - Interim Ratios
- Financial Ratios - Ratio Charts
- Section 4 – Company’s Lifesciences, Power Financial Deals and Alliances
- GSK plc, Pharmaceuticals & Healthcare, Deals By Year, 2019 to YTD 2025
- GSK plc, Pharmaceuticals & Healthcare, Deals By Type, 2019 to YTD 2025
- GSK plc, Recent Deals Summary
- Section 5 – Company’s Recent Developments
- May 15, 2025: New Allegations About Timing of Pfizer COVID Vaccine Passed To House Panel
- May 09, 2025: GSK and Lifetime Launch Original Movie To Raise Awareness About the Impact of Meningitis
- Apr 30, 2025: GSK Announces Q1 Results
- Apr 15, 2025: Abu Dhabi Investment Office and GSK sign agreement to establish Multi-Omics Research Institute in Abu Dhabi during Abu Dhabi Global Health Week 2025
- Apr 09, 2025: GSK Announces Recipients of COiMMUNITY Initiative Grant Program
- Apr 07, 2025: ABL Bio and GSK link on neurodegenerative conditions
- Mar 25, 2025: GSK, UK Dementia Research Institute (UK DRI) and Health Data Research UK (HDR UK) to Collaborate on First-Of-Its-Kind Dementia Research Initiative
- Mar 18, 2025: Curevo procures $110m and former-GSK exec for shingles vaccine candidate
- Feb 26, 2025: Zymeworks Achieves $14M Milestone From GSK Collaboration
- Feb 21, 2025: GSK Announces Appointment of Gavin Screaton to Board
- Section 6 – Appendix
- Methodology
- Ratio Definitions
- About GlobalData
- Contact Us
- Disclaimer
- List of Tables
- GSK plc, Key Facts
- GSK plc, Key Employees
- GSK plc, Key Employee Biographies
- GSK plc, Major Products and Services
- GSK plc, History
- GSK plc, Other Locations
- GSK plc, Subsidiaries
- GSK plc, Joint Venture
- GSK plc, Key Competitors
- GSK plc, Ratios based on current share price
- GSK plc, Annual Ratios
- GSK plc, Annual Ratios (Cont...1)
- GSK plc, Annual Ratios (Cont...2)
- GSK plc, Interim Ratios
- GSK plc, Pharmaceuticals & Healthcare, Deals By Year, 2019 to YTD 2025
- GSK plc, Pharmaceuticals & Healthcare, Deals By Type, 2019 to YTD 2025
- GSK plc, Recent Deals Summary
- Currency Codes
- Capital Market Ratios
- Equity Ratios
- Profitability Ratios
- Cost Ratios
- Liquidity Ratios
- Leverage Ratios
- Efficiency Ratios
- List of Figures
- GSK plc, Performance Chart (2020 - 2024)
- GSK plc, Ratio Charts
- GSK plc, Pharmaceuticals & Healthcare, Deals By Year, 2019 to YTD 2025
- GSK plc, Pharmaceuticals & Healthcare, Deals by Type, 2019 to YTD 2025
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.